SOS2 Gene - SOS Ras/Rho Guanine Nucleotide Exchange Factor 2

Comprehensive biomedical resource for SOS2: genomic data, expression, mutations, and clinical significance.

Gene Information Card

Symbol SOS2
Full Name SOS Ras/Rho Guanine Nucleotide Exchange Factor 2
Gene Type Protein coding
Chromosomal Location 14q21.3
NCBI Gene ID 6654 ncbi.nlm.nih.gov/gene/6654
Ensembl ID ENSG00000100485
UniProt ID Q07889
OMIM ID 601247
HGNC ID 11188
Aliases SOS2, NS9, GF1, SOS-2

Description

SOS2 (SOS Ras/Rho Guanine Nucleotide Exchange Factor 2) is a protein-coding gene that encodes a guanine nucleotide exchange factor (GEF) for RAS and RHO family small GTPases. It activates RAS by promoting the exchange of GDP for GTP, playing a critical role in signal transduction pathways including MAPK/ERK signaling. SOS2 is involved in cell growth, differentiation, and survival. Mutations in SOS2 are associated with Noonan syndrome and certain cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Noonan syndrome 9 (NS9) Gain-of-function mutations in SOS2 lead to increased RAS activation, disrupting normal development. OMIM #616559; ClinVar
Hereditary gingival fibromatosis SOS2 mutations may contribute to abnormal cell proliferation in gingival tissue. OMIM #135400; PubMed
RASopathies SOS2 mutations cause dysregulation of the RAS-MAPK pathway, leading to syndromic disorders. OMIM; ClinVar
Cancer (various) Somatic mutations in SOS2 can promote oncogenic RAS signaling in tumors. COSMIC; PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 8.5 Medium
Heart 6.2 Medium
Liver 4.1 Low
Lung 5.8 Medium
Kidney 7.3 Medium
Testis 9.1 High
Cell Line Expression
Cell Line nTPM Notes
HEK 293 10.2 High expression
HeLa 7.8 Medium expression
A549 6.5 Medium expression
MCF7 5.1 Low expression
K562 8.9 High expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1654G>A (p.Gly552Arg) Missense <0.1% Gain-of-function; associated with Noonan syndrome
c.1255C>T (p.Arg419Trp) Missense <0.1% Gain-of-function; RAS pathway activation
c.2186C>T (p.Thr729Met) Missense <0.1% Likely pathogenic; Noonan syndrome
c.437A>G (p.Tyr146Cys) Missense <0.1% Uncertain significance
c.1234_1236del (p.Lys412del) Deletion <0.1% Loss-of-function; reduced GEF activity
Mutation functional classification

Loss of Function (LOF)

Rare deletions or nonsense mutations that reduce or abolish GEF activity, impairing RAS activation.

Gain of Function (GOF)

Missense mutations (e.g., p.Gly552Arg) that enhance GEF activity, leading to constitutive RAS signaling and Noonan syndrome.

Dominant Negative (DN)

Not well documented; some mutations may interfere with wild-type SOS2 function.

Pathways

RAS signaling pathway (Reactome: R-HSA-5673001)
MAPK/ERK signaling (KEGG: hsa04010)
Signaling by Receptor Tyrosine Kinases (Reactome: R-HSA-9006934)
Noonan syndrome pathway (KEGG: hsa05230)

Protein Summary

SOS2 is a 1333-amino acid protein with a molecular weight of ~152 kDa. It contains a Dbl homology (DH) domain, a pleckstrin homology (PH) domain, and a Ras exchanger motif (REM) domain. The protein functions as a guanine nucleotide exchange factor (GEF) for RAS and RHO GTPases, catalyzing the exchange of GDP for GTP. SOS2 is ubiquitously expressed and localizes to the cytoplasm and plasma membrane. It is regulated by phosphorylation and interaction with GRB2. Mutations in SOS2 are linked to Noonan syndrome and cancer.

Related Products

Product name Cat.No. Species Gene ID
SOS2 Knockout HEK293 Cell Line EDJ-KQ136 Human 6655 Details Get a Quote
SOS2 Knockout A-549 Cell Line EDJ-KQ18888 Human 6655 Details Get a Quote
SOS2 Knockout HCT 116 Cell Line EDJ-KQ18889 Human 6655 Details Get a Quote
SOS2 Knockout HeLa Cell Line EDJ-KQ18890 Human 6655 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: